DHP Korea Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 1.13%

DHP Korea Co. Ltd (131030) has an Asset Resilience Ratio of 1.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of DHP Korea Co. Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

₩1.99 Billion
≈ $1.35 Million USD Cash + Short-term Investments

Total Assets

₩175.59 Billion
≈ $119.00 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how DHP Korea Co. Ltd's Asset Resilience Ratio has changed over time. See 131030 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down DHP Korea Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see DHP Korea Co. Ltd (131030) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩1.99 Billion 1.13%
Total Liquid Assets ₩1.99 Billion 1.13%

Asset Resilience Insights

  • Limited Liquidity: DHP Korea Co. Ltd maintains only 1.13% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

DHP Korea Co. Ltd Industry Peers by Asset Resilience Ratio

Compare DHP Korea Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Drug Manufacturers - Specialty & Generic 43.05%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
Drug Manufacturers - Specialty & Generic 1.96%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Guobang Pharma Ltd
SHG:605507
Drug Manufacturers - Specialty & Generic 8.47%

Annual Asset Resilience Ratio for DHP Korea Co. Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for DHP Korea Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 18.32% ₩30.50 Billion
≈ $20.67 Million
₩166.50 Billion
≈ $112.84 Million
-17.62pp
2023-12-31 35.94% ₩53.71 Billion
≈ $36.40 Million
₩149.46 Billion
≈ $101.29 Million
-9.24pp
2022-12-31 45.18% ₩61.55 Billion
≈ $41.71 Million
₩136.24 Billion
≈ $92.33 Million
-4.49pp
2021-12-31 49.66% ₩69.55 Billion
≈ $47.13 Million
₩140.04 Billion
≈ $94.90 Million
-9.91pp
2020-12-31 59.58% ₩77.39 Billion
≈ $52.45 Million
₩129.90 Billion
≈ $88.03 Million
+1.45pp
2019-12-31 58.13% ₩69.15 Billion
≈ $46.86 Million
₩118.97 Billion
≈ $80.62 Million
+1.19pp
2018-12-31 56.94% ₩59.16 Billion
≈ $40.09 Million
₩103.91 Billion
≈ $70.42 Million
-0.63pp
2017-12-31 57.57% ₩54.45 Billion
≈ $36.90 Million
₩94.57 Billion
≈ $64.09 Million
+6.28pp
2016-12-31 51.29% ₩43.00 Billion
≈ $29.14 Million
₩83.85 Billion
≈ $56.82 Million
+47.18pp
2015-12-31 4.10% ₩3.00 Billion
≈ $2.03 Million
₩73.14 Billion
≈ $49.57 Million
+1.96pp
2014-12-31 2.14% ₩1.44 Billion
≈ $978.76K
₩67.39 Billion
≈ $45.67 Million
--
pp = percentage points

About DHP Korea Co. Ltd

KQ:131030 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$94.22 Million
₩139.03 Billion KRW
Market Cap Rank
#19406 Global
#1067 in Korea
Share Price
₩9090.00
Change (1 day)
-4.32%
52-Week Range
₩6040.00 - ₩19260.00
All Time High
₩19260.00
About

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more